Hou‐Quan Tao
- Cancer Research top 5%
- MicroRNA in disease regulation 8
- Cancer-related molecular mechanisms research 8
- Oncology top 5%
- Peptidase Inhibition and Analysis 7
- Pancreatic and Hepatic Oncology Research 5
- Molecular Biology top 10%
- Cancer-related gene regulation 8
- Angiogenesis and VEGF in Cancer 8
- Glycosylation and Glycoproteins Research 5
-
- Gastric Cancer Management and Outcomes 12
- Co-authors
- Zai‐yuan YeZhong‐Sheng ZhaoXujun HeYuanyu WangYingjie XiaHui‐Ju WangXiaoting JiangYingyu Ma
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Hou‐Quan Tao
76 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 95
- Cancer Research 587
- Oncology 466
- Molecular Biology 946
- Pulmonary and Respiratory Medicine 313
- Immunology 198
Countries citing papers authored by Hou‐Quan Tao
This map shows the geographic impact of Hou‐Quan Tao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hou‐Quan Tao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hou‐Quan Tao more than expected).
Fields of papers citing papers by Hou‐Quan Tao
This network shows the impact of papers produced by Hou‐Quan Tao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hou‐Quan Tao. The network helps show where Hou‐Quan Tao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hou‐Quan Tao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2023 | 5 | |
| 3 | 2021 | 10 | |
| 4 | 2019 | 12 | |
| 5 | 2014 | 19 | |
| 6 | 2014 | 29 | |
| 7 | 2014 | 13 | |
| 8 | [Expression of aldo-keto reductase family 1 member B10 in gastric cancer tissues and its clinical significance]. | 2013 | 3 |
| 9 | 2013 | 54 | |
| 10 | 2012 | 35 | |
| 11 | 2012 | 4 | |
| 12 | 2011 | 25 | |
| 13 | [Relationship between sphingosine kinase 1 expression and tumor invasion, metastasis and prognosis in gastric cancer]. | 2011 | 5 |
| 14 | 2011 | 28 | |
| 15 | 2010 | 61 | |
| 16 | 2010 | 29 | |
| 17 | 2010 | 34 | |
| 18 | [Effects of anti-heparanase antibody on the growth and invasion of HCCLM6 human hepatocellular carcinoma cells]. | 2009 | 4 |
| 19 | 2009 | 22 | |
| 20 | 2008 | 33 |
About Hou‐Quan Tao
Hou‐Quan Tao is a scholar working on Cancer Research, Immunology and Allergy and Oncology, having authored 77 papers that have together received 1.6k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (12 papers), MicroRNA in disease regulation (8 papers), Cancer-related gene regulation (8 papers), Cancer-related molecular mechanisms research (8 papers), Angiogenesis and VEGF in Cancer (8 papers), Peptidase Inhibition and Analysis (7 papers), Glycosylation and Glycoproteins Research (5 papers) and Pancreatic and Hepatic Oncology Research (5 papers). The work is most often cited by research in Cancer Research (587 citations), Oncology (466 citations) and Molecular Biology (946 citations). Hou‐Quan Tao has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Zai‐yuan Ye, Zhong‐Sheng Zhao, Xujun He, Yuanyu Wang, Yingjie Xia, Hui‐Ju Wang, Xiaoting Jiang, Yingyu Ma, Ying‐Yu Ma and Jingxia Zhang. Their work appears in journals such as Journal of Clinical Oncology, The EMBO Journal and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.